OPF: oligo(poly(ethylene glycol) fumarate)
Oliver Sum-Ping, MD, a Clinical Associate Professor of Psychiatry and Sleep Medicine at Stanford Medicine who wasnt affiliated with the research told Healthline, The results suggest substantial potential for the role of these medications for at least mitigating OSA. The SURMOUNT-OSA trial was a multi-center, randomized, double-blind, placebo-controlled trial conducted with 469 patients, all of whom had OSA
Studies reporting metabolic outcomes were the most common, followed by renal and cardiovascular outcomes
Revascularization is an effective strategy for salvaging ischemic myocardium in myocardial infarction [194, 195], while restoration of blood flow to the ischemic myocardium paradoxically exacerbates cardiac tissue damage, a phenomenon known as myocardial ischemiareperfusion (I/R) injury [196, 197]